<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32639008</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2397-8554</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>11</Day></PubDate></JournalIssue><Title>Emerging topics in life sciences</Title><ISOAbbreviation>Emerg Top Life Sci</ISOAbbreviation></Journal><ArticleTitle>Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD.</ArticleTitle><Pagination><StartPage>293</StartPage><EndPage>305</EndPage><MedlinePgn>293-305</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1042/ETLS20190167</ELocationID><Abstract><AbstractText>A hexanucleotide repeat expansion GGGGCC (G4C2) within chromosome 9 open reading frame 72 (C9orf72) is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia (C9-ALS/FTD). This seminal realization has rapidly focused our attention to the non-canonical translation (RAN translation) of the repeat expansion, which yields dipeptide-repeat protein products (DPRs). The mechanisms by which DPRs might contribute to C9-ALS/FTD are widely studied. Arginine-rich DPRs (R-DPRs) are the most toxic of the five different DPRs produced in neurons, but how do R-DPRs promote C9-ALS/FTD pathogenesis? Proteomic analyses have uncovered potential pathways to explore. For example, the vast majority of the R-DPR interactome is comprised of disease-linked RNA-binding proteins (RBPs) with low-complexity domains (LCDs), strongly suggesting a link between R-DPRs and aberrations in liquid-liquid phase separation (LLPS). In this review, we showcase several potential mechanisms by which R-DPRs disrupt various phase-separated compartments to elicit deleterious neurodegeneration. We also discuss potential therapeutic strategies to counter R-DPR toxicity in C9-ALS/FTD.</AbstractText><CopyrightInformation>&#xa9; 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society and the Royal Society of Biology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Odeh</LastName><ForeName>Hana M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorter</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, U.S.A.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM099836</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG065854</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS090205</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Emerg Top Life Sci</MedlineTA><NlmUniqueID>101706399</NlmUniqueID><ISSNLinking>2397-8554</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="Y">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">RAN translation</Keyword><Keyword MajorTopicYN="N">dipeptide-repeat proteins</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">phase separation</Keyword></KeywordList><CoiStatement>Competing Interests. The authors declare that there are no competing interests associated with the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32639008</ArticleId><ArticleId IdType="mid">NIHMS1674619</ArticleId><ArticleId IdType="pmc">PMC7935415</ArticleId><ArticleId IdType="doi">10.1042/ETLS20190167</ArticleId><ArticleId IdType="pii">225720</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ji A-L, Zhang X, Chen W-W and Huang W-J (2017) Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum. J. Med. Genet 54, 145&#x2013;154 10.1136/jmedgenet-2016-104271</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2016-104271</ArticleId><ArticleId IdType="pubmed">28087719</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RHJ and Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539, 197&#x2013;206 10.1038/nature20413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH and Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N. Engl. J. Med 377, 1602 10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Statland JM, Barohn RJ, McVey AL, Katz JS and Dimachkie MM (2015) Patterns of weakness, classification of motor neuron disease, and clinical diagnosis of sporadic amyotrophic lateral sclerosis. Neurol. Clin 33, 735&#x2013;748 10.1016/j.ncl.2015.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.006</ArticleId><ArticleId IdType="pmc">PMC4629510</ArticleId><ArticleId IdType="pubmed">26515618</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245&#x2013;256 10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257&#x2013;268 10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A, Al Khleifat A, Jones AR, Sproviero W, Shatunov A, Opie-Martin S et al. (2019) C9orf72 intermediate expansions of 24&#x2013;30 repeats are associated with ALS. Acta Neuropathol. Commun 7, 115 10.1186/s40478-019-0724-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0724-4</ArticleId><ArticleId IdType="pmc">PMC6637621</ArticleId><ArticleId IdType="pubmed">31315673</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD and Tsuiji H (2016) There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS. Brain Res. 1647, 19&#x2013;29 10.1016/j.brainres.2016.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.004</ArticleId><ArticleId IdType="pmc">PMC5003651</ArticleId><ArticleId IdType="pubmed">27059391</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W and Van Den Bosch L (2020) RNA toxicity in non-coding repeat expansion disorders. EMBO J. 39, e101112 10.15252/embj.2018101112</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018101112</ArticleId><ArticleId IdType="pmc">PMC6939197</ArticleId><ArticleId IdType="pubmed">31721251</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD and Taylor JP (2017) The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front. Mol. Neurosci 10, 35 10.3389/fnmol.2017.00035</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite AJ, B&#xe4;umer D, East S, Neal J, Morris HR, Ansorge O et al. (2014) Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging 35, 1779.e5&#x2013;1779.e13 10.1016/j.neurobiolaging.2014.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.016</ArticleId><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S, Subramanian V and Acharya KR (2018) C9orf72, a protein associated with amyotrophic lateral sclerosis (ALS) is a guanine nucleotide exchange factor. PeerJ 6, e5815 10.7717/peerj.5815</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.5815</ArticleId><ArticleId IdType="pmc">PMC6195791</ArticleId><ArticleId IdType="pubmed">30356970</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A et al. (2013) Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann. Neurol 74, 180&#x2013;187 10.1002/ana.23946</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23946</ArticleId><ArticleId IdType="pubmed">23720273</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M, Rouleau GA, Dion PA and Parker JA (2013) Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS One 8, e83450 10.1371/journal.pone.0083450</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083450</ArticleId><ArticleId IdType="pmc">PMC3861484</ArticleId><ArticleId IdType="pubmed">24349511</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M, Blokhuis AM, Westeneng H-J, Terpstra ML, Zundel CAC, Vieira de S&#xe1; R et al. (2015) C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann. Neurol 78, 426&#x2013;438 10.1002/ana.24453</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24453</ArticleId><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A et al. (2020) Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat. Neurosci 23, 615&#x2013;624 10.1038/s41593-020-0619-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo-Rady M, Kalmbach N, Pal A, Schludi C, Janosch A, Richter T et al. (2020) Knocking out C9ORF72 exacerbates axonal trafficking defects associated with hexanucleotide repeat expansion and reduces levels of heat shock proteins. Stem Cell Rep. 14, 390&#x2013;405 10.1016/j.stemcr.2020.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.01.010</ArticleId><ArticleId IdType="pmc">PMC7066330</ArticleId><ArticleId IdType="pubmed">32084385</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke JG, Bogdanik L, Yanez A, Lall D, Wolf AJ, Muhammad AKMG et al. (2016) C9orf72 is required for proper macrophage and microglial function in mice. Science 351, 1324&#x2013;1329 10.1126/science.aaf1064</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Wells MF, Limone F, Couto A, Smith KS, Keaney J et al. (2020) C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582, 89&#x2013;94 10.1038/s41586-020-2288-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang P and Hsiao EY (2020) Gut microbes tune inflammation and lifespan in a mouse model of amyotrophic lateral sclerosis. Nature 582, 34&#x2013;35 10.1038/d41586-020-01335-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-01335-3</ArticleId><ArticleId IdType="pubmed">32405038</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang Y-J, Jansen-West K, Ash PEA, Caulfield T et al. (2013) Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 126, 829&#x2013;844 10.1007/s00401-013-1192-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Lashley T, Norona FE, Clayton EL, Ridler CE, Fratta P et al. (2013) C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol. 126, 845&#x2013;857 10.1007/s00401-013-1200-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1200-z</ArticleId><ArticleId IdType="pmc">PMC3830745</ArticleId><ArticleId IdType="pubmed">24170096</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K, Zamiri B, Stanley SYR, Macgregor RB and Pearson CE (2013) The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J. Biol. Chem 288, 9860&#x2013;9866 10.1074/jbc.C113.452532</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C113.452532</ArticleId><ArticleId IdType="pmc">PMC3617286</ArticleId><ArticleId IdType="pubmed">23423380</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Periz G, Simko EAJ, Shaw PG, Kim M-S et al. (2014) C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507, 195&#x2013;200 10.1038/nature13124</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A and Vale RD (2017) RNA phase transitions in repeat expansion disorders. Nature 546, 243&#x2013;247 10.1038/nature22386</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22386</ArticleId><ArticleId IdType="pmc">PMC5555642</ArticleId><ArticleId IdType="pubmed">28562589</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon EG Lu L, Sharma A, Yamazaki T, Tang T, Shneider NA et al. (2016) The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. eLife 5, e17820 10.7554/eLife.17820</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.17820</ArticleId><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF and Petrucelli L (2018) Disease mechanisms of C9ORF72 repeat expansions. Cold Spring Harb. Perspect. Med 8, a024224 10.1101/cshperspect.a024224</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024224</ArticleId><ArticleId IdType="pmc">PMC5880161</ArticleId><ArticleId IdType="pubmed">28130314</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang P-W, Pham JT, Haeusler AR, Heusler AR, Mistry NA et al. (2013) RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80, 415&#x2013;428 10.1016/j.neuron.2013.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD et al. (2011) Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl. Acad. Sci. U.S.A 108, 260&#x2013;265 10.1073/pnas.1013343108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1013343108</ArticleId><ArticleId IdType="pmc">PMC3017129</ArticleId><ArticleId IdType="pubmed">21173221</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Arzberger T, Gr&#xe4;sser FA, Gijselinck I, May S, Rentzsch K et al. (2013) Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 126, 881&#x2013;893 10.1007/s00401-013-1189-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Liu Y, Ba&#xf1;ez-Coronel M, Reid T, Pletnikova O, Lewis J et al. (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. U.S.A 110, E4968&#x2013;E4977 10.1073/pnas.1315438110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Frick P, Gr&#xe4;sser FA, Gendron TF, Petrucelli L, Cashman NR et al. (2015) Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 130, 845&#x2013;861 10.1007/s00401-015-1476-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1476-2</ArticleId><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee K-H et al. (2015) GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525, 129&#x2013;133 10.1038/nature14974</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-J, Jansen-West K, Xu Y-F, Gendron TF, Bieniek KF, Lin W-L et al. (2014) Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 128, 505&#x2013;524 10.1007/s00401-014-1336-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1336-5</ArticleId><ArticleId IdType="pmc">PMC4159567</ArticleId><ArticleId IdType="pubmed">25173361</ArticleId></ArticleIdList></Reference><Reference><Citation>May S, Hornburg D, Schludi MH, Arzberger T, Rentzsch K, Schwenk BM et al. (2014) C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 128, 485&#x2013;503 10.1007/s00401-014-1329-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1329-4</ArticleId><ArticleId IdType="pmc">PMC4159571</ArticleId><ArticleId IdType="pubmed">25120191</ArticleId></ArticleIdList></Reference><Reference><Citation>Darling AL, Breydo L, Rivas EG Gebru NT, Zheng D, Baker JD et al. (2019) Repeated repeat problems: combinatorial effect of C9orf72-derived dipeptide repeat proteins. Int. J. Biol. Macromol 127, 136&#x2013;145 10.1016/j.ijbiomac.2019.01.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2019.01.035</ArticleId><ArticleId IdType="pubmed">30639592</ArticleId></ArticleIdList></Reference><Reference><Citation>McEachin ZT, Gendron TF, Raj N, Garc&#xed;a-Murias M, Banerjee A, Purcell RH et al. (2020) Chimeric peptide species contribute to divergent dipeptide repeat pathology in c9ALS/FTD and SCA36. Neuron 10.1016/j.neuron.2020.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.04.011</ArticleId><ArticleId IdType="pmc">PMC8138626</ArticleId><ArticleId IdType="pubmed">32375063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, Krishnamurthy K, Markandaiah SS, Shi Y et al. (2014) Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 84, 1213&#x2013;1225 10.1016/j.neuron.2014.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Gr&#xf6;nke S, Niccoli T, Ridler CE, Clayton EL, Devoy A et al. (2014) C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345, 1192&#x2013;1194 10.1126/science.1256800</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K-H, Zhang P, Kim HJ, Mitrea DM, Sarkar M, Freibaum BD et al. (2016) C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell 167, 774&#x2013;788.e17 10.1016/j.cell.2016.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z, Wang H, Xia Q, Li K, Li K, Jiang X et al. (2015) Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity. Hum. Mol. Genet 24, 2426&#x2013;2441 10.1093/hmg/ddv005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv005</ArticleId><ArticleId IdType="pubmed">25575510</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I, Xiang S, Kato M, Wu L, Theodoropoulos P, Wang T et al. (2014) Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 345, 1139&#x2013;1145 10.1126/science.1254917</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254917</ArticleId><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens TG, Niccoli T, Wilson KM, Atilano ML, Birsa N, Gittings LM et al. (2019) C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. Acta Neuropathol. 137, 487&#x2013;500 10.1007/s00401-018-1946-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1946-4</ArticleId><ArticleId IdType="pmc">PMC6514073</ArticleId><ArticleId IdType="pubmed">30604225</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H, Hornburg D, Czuppa M, Bader J, Michaelsen M, Farny D et al. (2018) Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity. Life Sci Alliance 1, e201800070 10.26508/lsa.201800070</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201800070</ArticleId><ArticleId IdType="pmc">PMC6238541</ArticleId><ArticleId IdType="pubmed">30456350</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S, Lopez-Gonzalez R, Kunz RC, Gangopadhyay J, Borufka C, Gygi SP et al. (2017) Evidence that C9ORF72 dipeptide repeat proteins associate with U2 snRNP to cause mis-splicing in ALS/FTD patients. Cell Rep. 19, 2244&#x2013;2256 10.1016/j.celrep.2017.05.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.056</ArticleId><ArticleId IdType="pmc">PMC5653973</ArticleId><ArticleId IdType="pubmed">28614712</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Mori E, Kato M, Xiang S, Wu L, Kwon I et al. (2016) Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers. Cell 167, 789&#x2013;802.e12 10.1016/j.cell.2016.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.003</ArticleId><ArticleId IdType="pmc">PMC5076566</ArticleId><ArticleId IdType="pubmed">27768897</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Michiels E, Gijselinck I, Sieben A, Jovi&#x10d;ic A et al. (2016) Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep 6, 20877 10.1038/srep20877</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20877</ArticleId><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman AA, Weber CA and J&#xfc;licher F (2014) Liquid-liquid phase separation in biology. Annu. Rev. Cell Dev. Biol 30, 39&#x2013;58 10.1146/annurev-cellbio-100913-013325</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100913-013325</ArticleId><ArticleId IdType="pubmed">25288112</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes E and Shorter J (2019) The molecular language of membraneless organelles. J. Biol. Chem 294, 7115&#x2013;7127 10.1074/jbc.TM118.001192</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.001192</ArticleId><ArticleId IdType="pmc">PMC6509512</ArticleId><ArticleId IdType="pubmed">30045872</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Alberti S, Fawzi NL, Mittag T, Polymenidou M, Rousseau F et al. (2018) Protein phase separation: a new phase in cell biology. Trends Cell Biol. 28, 420&#x2013;435 10.1016/j.tcb.2018.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.02.004</ArticleId><ArticleId IdType="pmc">PMC6034118</ArticleId><ArticleId IdType="pubmed">29602697</ArticleId></ArticleIdList></Reference><Reference><Citation>Malinovska L, Kroschwald S and Alberti S (2013) Protein disorder, prion propensities, and self-organizing macromolecular collectives. Biochim. Biophys. Acta 1834, 918&#x2013;931 10.1016/j.bbapap.2013.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2013.01.003</ArticleId><ArticleId IdType="pubmed">23328411</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne CP, Tompa P and Pappu RV (2015) Polymer physics of intracellular phase transitions. Nat. Phys 11, 899&#x2013;904 10.1038/nphys3532</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nphys3532</ArticleId></ArticleIdList></Reference><Reference><Citation>March ZM, King OD and Shorter J (2016) Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res. 1647, 9&#x2013;18 10.1016/j.brainres.2016.02.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.02.037</ArticleId><ArticleId IdType="pmc">PMC5003744</ArticleId><ArticleId IdType="pubmed">26996412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kim NC, Wang Y-D, Scarborough EA, Moore J, Diaz Z et al. (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467&#x2013;473 10.1038/nature11922</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY et al. (2015) A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162, 1066&#x2013;1077 10.1016/j.cell.2015.07.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ et al. (2015) Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163, 123&#x2013;133 10.1016/j.cell.2015.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J and Gitler AD (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem 284, 20329&#x2013;20339 10.1074/jbc.M109.010264</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG et al. (2019) RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron 102, 321&#x2013;338.e8 10.1016/j.neuron.2019.01.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky NB and Taylor JP (2019) Bridging biophysics and neurology: aberrant phase transitions in neurodegenerative disease. Nat. Rev. Neurol 15, 272&#x2013;286 10.1038/s41582-019-0157-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0157-5</ArticleId><ArticleId IdType="pubmed">30890779</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R and Isaacs AM (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol 14, 544&#x2013;558 10.1038/s41582-018-0047-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Deza J, Lee Y-B, Troakes C, Nolan M, Al-Sarraj S, Gallo J-M et al. (2015) Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration. Acta Neuropathol. Commun 3, 38 10.1186/s40478-015-0218-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0218-y</ArticleId><ArticleId IdType="pmc">PMC4479315</ArticleId><ArticleId IdType="pubmed">26108573</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Jiang J, Garcia SD, Taylor AE, Schulte D et al. (2018) Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 135, 459&#x2013;474 10.1007/s00401-017-1793-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1793-8</ArticleId><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Bento-Abreu A, Gendron TF, Boeynaems S, Bogaert E, Nuyts R et al. (2018) A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 135, 427&#x2013;443 10.1007/s00401-017-1796-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens TG, Mizielinska S, Niccoli T, Mitchell JS, Thoeng A, Ridler CE et al. (2018) Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD. Acta Neuropathol. 135, 445&#x2013;457 10.1007/s00401-017-1798-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1798-3</ArticleId><ArticleId IdType="pmc">PMC6385858</ArticleId><ArticleId IdType="pubmed">29380049</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada SB, Gendron TF, Niccoli T, Genuth NR, Grosely R, Shi Y et al. (2019) RPS25 is required for efficient RAN translation of C9orf72 and other neurodegenerative disease-associated nucleotide repeats. Nat. Neurosci 22, 1383&#x2013;1388 10.1038/s41593-019-0455-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0455-7</ArticleId><ArticleId IdType="pmc">PMC6713615</ArticleId><ArticleId IdType="pubmed">31358992</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Flores BN, Krans A, Frazer M, Natla S, Niraula S et al. (2020) The carboxyl-termini of RAN translated GGGGCC nucleotide repeat expansions modulate toxicity in models of ALS/FTD. bioRxiv 10.1101/2020.05.27.119651</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.27.119651</ArticleId><ArticleId IdType="pmc">PMC7401224</ArticleId><ArticleId IdType="pubmed">32753055</ArticleId></ArticleIdList></Reference><Reference><Citation>Boisvert F-M, van Koningsbruggen S, Navascu&#xe9;s J and Lamond AI (2007) The multifunctional nucleolus. Nat. Rev. Mol. Cell Biol 8, 574&#x2013;585 10.1038/nrm2184</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2184</ArticleId><ArticleId IdType="pubmed">17519961</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne CP, Mitchison TJ and Hyman AA (2011) Active liquid-like behavior of nucleoli determines their size and shape in Xenopus laevis oocytes. Proc. Natl. Acad. Sci. U.S.A 108, 4334&#x2013;4339 10.1073/pnas.1017150108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017150108</ArticleId><ArticleId IdType="pmc">PMC3060270</ArticleId><ArticleId IdType="pubmed">21368180</ArticleId></ArticleIdList></Reference><Reference><Citation>Feric M, Vaidya N, Harmon TS, Mitrea DM, Zhu L, Richardson TM et al. (2016) Coexisting liquid phases underlie nucleolar subcompartments. Cell 165, 1686&#x2013;1697 10.1016/j.cell.2016.04.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.047</ArticleId><ArticleId IdType="pmc">PMC5127388</ArticleId><ArticleId IdType="pubmed">27212236</ArticleId></ArticleIdList></Reference><Reference><Citation>White MR, Mitrea DM, Zhang P, Stanley CB, Cassidy DE, Nourse A et al. (2019) C9orf72 Poly(PR) dipeptide repeats disturb biomolecular phase separation and disrupt nucleolar function. Mol. Cell 74, 713&#x2013;728.e6 10.1016/j.molcel.2019.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.03.019</ArticleId><ArticleId IdType="pmc">PMC6525025</ArticleId><ArticleId IdType="pubmed">30981631</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrea DM, Grace CR, Buljan M, Yun M-K, Pytel NJ, Satumba J et al. (2014) Structural polymorphism in the N-terminal oligomerization domain of NPM1. Proc. Natl. Acad. Sci. U.S.A 111, 4466&#x2013;4471 10.1073/pnas.1321007111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1321007111</ArticleId><ArticleId IdType="pmc">PMC3970533</ArticleId><ArticleId IdType="pubmed">24616519</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Ridler CE, Balendra R, Thoeng A, Woodling NS, Gr&#xe4;sser FA et al. (2017) Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration. Acta Neuropathol. Commun 5, 29 10.1186/s40478-017-0432-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0432-x</ArticleId><ArticleId IdType="pmc">PMC5395972</ArticleId><ArticleId IdType="pubmed">28420437</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, May S, Gr&#xe4;sser FA et al. (2015) Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol. 130, 537&#x2013;555 10.1007/s00401-015-1450-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1450-z</ArticleId><ArticleId IdType="pmc">PMC4575390</ArticleId><ArticleId IdType="pubmed">26085200</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson P and Kedersha N (2009) RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nat. Rev. Mol. Cell Biol 10, 430&#x2013;436 10.1038/nrm2694</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2694</ArticleId><ArticleId IdType="pubmed">19461665</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong A, Matheny T, Jain S, Mitchell SF, Wheeler JR and Parker R (2017) The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. Mol. Cell 68, 808&#x2013;820.e5 10.1016/j.molcel.2017.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.10.015</ArticleId><ArticleId IdType="pmc">PMC5728175</ArticleId><ArticleId IdType="pubmed">29129640</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Wheeler JR, Walters RW, Agrawal A, Barsic A and Parker R (2016) ATPase-modulated stress granules contain a diverse proteome and substructure. Cell 164, 487&#x2013;498 10.1016/j.cell.2015.12.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.038</ArticleId><ArticleId IdType="pmc">PMC4733397</ArticleId><ArticleId IdType="pubmed">26777405</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S, Soltanieh S, Server KL, Mak R, Jin W, Fang MY et al. (2018) Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell 172, 590&#x2013;604.e13 10.1016/j.cell.2017.12.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.032</ArticleId><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>Iserman C, Desroches Altamirano C, Jegers C, Friedrich U, Zarin T, Fritsch AW et al. (2020) Condensation of Ded1p promotes a translational switch from housekeeping to stress protein production. Cell 181, 818&#x2013;831.e19 10.1016/j.cell.2020.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7237889</ArticleId><ArticleId IdType="pubmed">32359423</ArticleId></ArticleIdList></Reference><Reference><Citation>Riback JA, Katanski CD, Kear-Scott JL, Pilipenko EV, Rojek AE, Sosnick TR et al. (2017) Stress-triggered phase separation is an adaptive, evolutionarily tuned response. Cell 168, 1028&#x2013;1040.e19 10.1016/j.cell.2017.02.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.02.027</ArticleId><ArticleId IdType="pmc">PMC5401687</ArticleId><ArticleId IdType="pubmed">28283059</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YR, King OD, Shorter J and Gitler AD (2013) Stress granules as crucibles of ALS pathogenesis. J. Cell Biol 201, 361&#x2013;372 10.1083/jcb.201302044</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Fan B, Yang P, Temirov J, Messing J, Kim HJ et al. (2019) Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology. eLife 8, e39578 10.7554/eLife.39578</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.39578</ArticleId><ArticleId IdType="pmc">PMC6426440</ArticleId><ArticleId IdType="pubmed">30893049</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo PK, Lee SJ, Jaiswal PB, Alber S, Kar AN, Miller-Randolph S et al. (2018) Axonal G3BP1 stress granule protein limits axonal mRNA translation and nerve regeneration. Nat. Commun 9, 3358 10.1038/s41467-018-05647-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05647-x</ArticleId><ArticleId IdType="pmc">PMC6105716</ArticleId><ArticleId IdType="pubmed">30135423</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, Gomes E, Guo L, Mojsilovic-Petrovic J, Tran V, Kalb RG et al. (2018) Poly(ADP-Ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol. Cell 71, 703&#x2013;717.e9 10.1016/j.molcel.2018.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-J, Gendron TF, Ebbert MTW, O&#x2019;Raw AD, Yue M, Jansen-West K et al. (2018) Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat. Med 24, 1136&#x2013;1142 10.1038/s41591-018-0071-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0071-1</ArticleId><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Kovacs D, Konijnenberg A, Timmerman E, Volkov A, et al. (2017) Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol. Cell 65, 1044&#x2013;1055.e5 10.1016/j.molcel.2017.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.02.013</ArticleId><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Holehouse AS, Weinhardt V, Kovacs D, Van Lindt J, Larabell C, et al. (2019) Spontaneous driving forces give rise to protein-RNA condensates with coexisting phases and complex material properties. Proc. Natl. Acad. Sci. U.S.A 116, 7889&#x2013;7898 10.1073/pnas.1821038116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1821038116</ArticleId><ArticleId IdType="pmc">PMC6475405</ArticleId><ArticleId IdType="pubmed">30926670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoelz A, Debler EW and Blobel G (2011) The structure of the nuclear pore complex. Annu. Rev. Biochem 80, 613&#x2013;643 10.1146/annurev-biochem-060109-151030</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060109-151030</ArticleId><ArticleId IdType="pubmed">21495847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez CM and Todd PK (2019) New pathologic mechanisms in nucleotide repeat expansion disorders. Neurobiol. Dis 130, 104515 10.1016/j.nbd.2019.104515</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104515</ArticleId><ArticleId IdType="pmc">PMC6689435</ArticleId><ArticleId IdType="pubmed">31229686</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt HB and G&#xf6;rlich D (2016) Transport selectivity of nuclear pores, phase separation, and membraneless organelles. Trends Biochem. Sci 41, 46&#x2013;61 10.1016/j.tibs.2015.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.11.001</ArticleId><ArticleId IdType="pubmed">26705895</ArticleId></ArticleIdList></Reference><Reference><Citation>Celetti G, Paci G, Caria J, VanDelinder V, Bachand G and Lemke EA (2020) The liquid state of FG-nucleoporins mimics permeability barrier properties of nuclear pore complexes. J. Cell Biol 219, e201907157 10.1083/jcb.201907157</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201907157</ArticleId><ArticleId IdType="pmc">PMC7039189</ArticleId><ArticleId IdType="pubmed">31723007</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;ic A, Mertens J, Boeynaems S, Bogaert E, Chai N, Yamada SB et al. (2015) Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci 18, 1226&#x2013;1229 10.1038/nn.4085</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Daigle JG, Cunningham KM, Coyne AN, Ruan K, Grima JC et al. (2018) Stress granule assembly disrupts nucleocytoplasmic transport. Cell 173, 958&#x2013;971.e17 10.1016/j.cell.2018.03.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi KY, Mori E, Nizami ZF, Lin Y, Kato M, Xiang S et al. (2017) Toxic PR n poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc. Natl. Acad. Sci. U.S.A 114, E1111&#x2013;E1117 10.1073/pnas.1620293114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1620293114</ArticleId><ArticleId IdType="pmc">PMC5320981</ArticleId><ArticleId IdType="pubmed">28069952</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J, Vercruysse T, Boeynaems S, Sicart A, Van Damme P, Daelemans D et al. (2019) C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport. Sci. Rep 9, 15728 10.1038/s41598-019-52035-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52035-6</ArticleId><ArticleId IdType="pmc">PMC6823349</ArticleId><ArticleId IdType="pubmed">31673013</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LR, Duan L, Bowen K, Kalab P and Rothstein JD (2020) C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. eLife 9, e51685 10.7554/eLife.51685</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.51685</ArticleId><ArticleId IdType="pmc">PMC7051184</ArticleId><ArticleId IdType="pubmed">32119645</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanaura H, Kawamukai H, Fujiwara A, Uehara T, Nakanishi M, Shiota T et al. (2019) Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target Kap&#x3b2;2 and dysregulate phase separation of low-complexity domains. bioRxiv, 812099 10.1101/812099</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/812099</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-J, Guo L, Gonzales PK, Gendron TF, Wu Y, Jansen-West K et al. (2019) Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science 363, eaav2606 10.1126/science.aav2606</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav2606</ArticleId><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>Eissenberg JC and Elgin SCR (2014) HP1a: a structural chromosomal protein regulating transcription. Trends Genet. 30, 103&#x2013;110 10.1016/j.tig.2014.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2014.01.002</ArticleId><ArticleId IdType="pmc">PMC3991861</ArticleId><ArticleId IdType="pubmed">24555990</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson AG, Elnatan D, Keenen MM, Trnka MJ, Johnston JB, Burlingame AL et al. (2017) Liquid droplet formation by HP1&#x3b1; suggests a role for phase separation in heterochromatin. Nature 547, 236&#x2013;240 10.1038/nature22822</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22822</ArticleId><ArticleId IdType="pmc">PMC5606208</ArticleId><ArticleId IdType="pubmed">28636604</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanulli S, Trnka MJ, Dharmarajan V, Tibble RW, Pascal BD, Burlingame AL et al. (2019) HP1 reshapes nucleosome core to promote phase separation of heterochromatin. Nature 575, 390&#x2013;394 10.1038/s41586-019-1669-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1669-2</ArticleId><ArticleId IdType="pmc">PMC7039410</ArticleId><ArticleId IdType="pubmed">31618757</ArticleId></ArticleIdList></Reference><Reference><Citation>Strom AR, Emelyanov AV, Mir M, Fyodorov DV, Darzacq X and Karpen GH (2017) Phase separation drives heterochromatin domain formation. Nature 547, 241&#x2013;245 10.1038/nature22989</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22989</ArticleId><ArticleId IdType="pmc">PMC6022742</ArticleId><ArticleId IdType="pubmed">28636597</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, Shorter J, Ha T and Myong S (2020) Just took a DNA test, turns out 100% not that phase. Mol. Cell 78, 193&#x2013;194 10.1016/j.molcel.2020.03.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.03.029</ArticleId><ArticleId IdType="pubmed">32302539</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdel F, Rademacher A, Vlijm R, Tunnermann J, Frank L, Weinmann R et al. (2020) Mouse heterochromatin adopts digital compaction states without showing hallmarks of HP1-driven liquid&#x2013;liquid phase separation. Mol. Cell 78, 236&#x2013;249.e7 10.1016/j.molcel.2020.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.02.005</ArticleId><ArticleId IdType="pmc">PMC7163299</ArticleId><ArticleId IdType="pubmed">32101700</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh PB and Newman AG (2020) On the relations of phase separation and Hi-C maps to epigenetics. R. Soc. Open Sci 7, 191976 10.1098/rsos.191976</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.191976</ArticleId><ArticleId IdType="pmc">PMC7062049</ArticleId><ArticleId IdType="pubmed">32257349</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Zerze GH, Mittal J and Fawzi NL (2016) ALS mutations disrupt phase separation mediated by &#x3b1;-helical structure in the TDP-43 low-complexity C-terminal domain. Structure 24, 1537&#x2013;1549 10.1016/j.str.2016.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L et al. (2019) Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102, 339&#x2013;357.e7 10.1016/j.neuron.2019.02.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun 351, 602&#x2013;611 10.1016/j.bbrc.2006.10.093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L and Shorter J (2017) Biology and pathobiology of TDP-43 and emergent therapeutic strategies. Cold Spring Harb. Perspect. Med 7, a024554 10.1101/cshperspect.a024554</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024554</ArticleId><ArticleId IdType="pmc">PMC5580514</ArticleId><ArticleId IdType="pubmed">27920024</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Cook C, Gendron TF, Jansen-West K, Del Rosso G, Daughrity LM et al. (2019) Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol. Neurodegener 14, 9 10.1186/s13024-019-0310-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0310-z</ArticleId><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ et al. (2015) Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene. Neuropathol. Appl. Neurobiol 41, 601&#x2013;612 10.1111/nan.12178</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12178</ArticleId><ArticleId IdType="pmc">PMC4934135</ArticleId><ArticleId IdType="pubmed">25185840</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C-C, Zhang Y, Umoh ME, Vaughan SW, Lorenzini I, Liu F et al. (2018) TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci 21, 228&#x2013;239 10.1038/s41593-017-0047-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM and Baralle FE (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem 280, 37572&#x2013;37584 10.1074/jbc.M505557200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M505557200</ArticleId><ArticleId IdType="pubmed">16157593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ, Carlomagno Y, Zhang Y-J, Almeida S, Cook CN, Gendron TF et al. (2016) Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science 353, 708&#x2013;712 10.1126/science.aaf7791</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf7791</ArticleId><ArticleId IdType="pmc">PMC5823025</ArticleId><ArticleId IdType="pubmed">27516603</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD, Prudencio M, Kramer NJ, Martinez-Ramirez LF, Srinivasan AR, Lan M et al. (2019) Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD. Nat. Neurosci 22, 863&#x2013;874 10.1038/s41593-019-0396-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0396-1</ArticleId><ArticleId IdType="pmc">PMC6535128</ArticleId><ArticleId IdType="pubmed">31110321</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W, Wang S, Zhang Z, Morgens DW, Hayes LR, Lee S et al. (2019) CRISPR-Cas9 screens identify the RNA helicase DDX3X as a repressor of C9ORF72 (GGGGCC)n repeat-associated non-AUG translation. Neuron 104, 885&#x2013;898.e8 10.1016/j.neuron.2019.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.09.003</ArticleId><ArticleId IdType="pmc">PMC6895427</ArticleId><ArticleId IdType="pubmed">31587919</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett CF, Krainer AR and Cleveland DW (2019) Antisense oligonucleotide therapies for neurodegenerative diseases. Annu. Rev. Neurosci 42, 385&#x2013;406 10.1146/annurev-neuro-070918-050501</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-070918-050501</ArticleId><ArticleId IdType="pmc">PMC7427431</ArticleId><ArticleId IdType="pubmed">31283897</ArticleId></ArticleIdList></Reference><Reference><Citation>Leavitt BR and Tabrizi SJ (2020) Antisense oligonucleotides for neurodegeneration. Science 367, 1428&#x2013;1429 10.1126/science.aba4624</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aba4624</ArticleId><ArticleId IdType="pubmed">32217715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li H-R et al. (2013) Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. U.S.A 110, E4530&#x2013;E4539 10.1073/pnas.1318835110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A et al. (2016) Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron 90, 535&#x2013;550 10.1016/j.neuron.2016.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L, Montrasio F, Pattamatta A, Tusi SK, Bardhi O, Meyer KD et al. (2020) Antibody therapy targeting RAN proteins rescues C9 ALS/FTD phenotypes in C9orf72 mouse model. Neuron 105, 645&#x2013;662.e11 10.1016/j.neuron.2019.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.11.007</ArticleId><ArticleId IdType="pmc">PMC7391607</ArticleId><ArticleId IdType="pubmed">31831332</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DG, Shorter J and Wobst HJ (2020) Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia. Bioorg. Med. Chem. Lett 30, 126942 10.1016/j.bmcl.2019.126942</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2019.126942</ArticleId><ArticleId IdType="pubmed">31926785</ArticleId></ArticleIdList></Reference><Reference><Citation>Wobst HJ, Mack KL, Brown DG, Brandon NJ and Shorter J (2020) The clinical trial landscape in amyotrophic lateral sclerosis-Past, present, and future. Med. Res. Rev 40, 1352&#x2013;1384 10.1002/med.21661</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21661</ArticleId><ArticleId IdType="pmc">PMC7417284</ArticleId><ArticleId IdType="pubmed">32043626</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang W-Y et al. (2014) Discovery of a biomarker and lead small molecules to target r (GGGGCC)-associated defects in c9FTD/ALS. Neuron 84, 239 10.1016/j.neuron.2014.09.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.09.019</ArticleId><ArticleId IdType="pubmed">28898625</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone R, Balendra R, Moens TG, Preza E, Wilson KM, Heslegrave A et al. (2018) G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo. EMBO Mol. Med 10, 22&#x2013;31 10.15252/emmm.201707850</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201707850</ArticleId><ArticleId IdType="pmc">PMC5760849</ArticleId><ArticleId IdType="pubmed">29113975</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R, Crippa V, Vezzoli G, Rusmini P, Galbiati M, Cicardi ME et al. (2018) The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases. Cell Stress Chaperones 23, 1&#x2013;12 10.1007/s12192-017-0806-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-017-0806-9</ArticleId><ArticleId IdType="pmc">PMC5741577</ArticleId><ArticleId IdType="pubmed">28608264</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Bao P, Jiang X, Wang H, Qin M, Wang R et al. (2019) Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity. Brain 142, 1349&#x2013;1364 10.1093/brain/awz070</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz070</ArticleId><ArticleId IdType="pmc">PMC6487333</ArticleId><ArticleId IdType="pubmed">30938419</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega JA, Daley EL, Kour S, Samani M, Tellez L, Smith HS et al. (2020) Nucleocytoplasmic proteomic analysis uncovers eRF1 and nonsense-mediated decay as modifiers of ALS/FTD C9orf72 toxicity. Neuron 106, 90&#x2013;107.e13 10.1016/j.neuron.2020.01.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.01.020</ArticleId><ArticleId IdType="pmc">PMC7272217</ArticleId><ArticleId IdType="pubmed">32059759</ArticleId></ArticleIdList></Reference><Reference><Citation>Odeh HM and Shorter J (2020) The sense of targeting nonsense-mediated decay in C9-ALS/FTD. Neuron 106, 6&#x2013;9 10.1016/j.neuron.2020.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.03.017</ArticleId><ArticleId IdType="pubmed">32272067</ArticleId></ArticleIdList></Reference><Reference><Citation>Gittings LM, Boeynaems S, Lightwood D, Clargo A, Topia S, Nakayama L et al. (2020) Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity. Acta Neuropathol. 139, 407&#x2013;410 10.1007/s00401-019-02104-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02104-x</ArticleId><ArticleId IdType="pmc">PMC6989575</ArticleId><ArticleId IdType="pubmed">31832771</ArticleId></ArticleIdList></Reference><Reference><Citation>Premasiri AS, Gill AL and Vieira FG (2020) Type I PRMT inhibition protects against C9ORF72 arginine-rich dipeptide repeat toxicity. bioRxiv 10.1101/2020.05.20.106260</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.20.106260</ArticleId><ArticleId IdType="pmc">PMC7508178</ArticleId><ArticleId IdType="pubmed">33013410</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Kim HJ, Wang H, Monaghan J, Freyermuth F, Sung JC et al. (2018) Nuclear-import receptors reverse aberrant phase transitions of RNA-BINDING PROTEINS WITH PRION-LIKE DOMains. Cell 173, 677&#x2013;692.e20 10.1016/j.cell.2018.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa T, Ali R, Jiou J, Fung HYJ, Burke KA, Kim SJ et al. (2018) Nuclear import receptor inhibits phase separation of FUS through binding to multiple sites. Cell 173, 693&#x2013;705.e22 10.1016/j.cell.2018.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.003</ArticleId><ArticleId IdType="pmc">PMC6234985</ArticleId><ArticleId IdType="pubmed">29677513</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Fare CM and Shorter J (2019) Therapeutic dissolution of aberrant phases by nuclear-import receptors. Trends Cell Biol. 29, 308&#x2013;322 10.1016/j.tcb.2018.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.12.004</ArticleId><ArticleId IdType="pmc">PMC6750949</ArticleId><ArticleId IdType="pubmed">30660504</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, Hutten S, Bourgeois B, Spreitzer E, Niedner-Boblenz A, Schifferer M et al. (2018) Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell 173, 706&#x2013;719.e13 10.1016/j.cell.2018.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.004</ArticleId><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S, Wang G, Randle SJ, Ruggeri FS, Varela JA, Lin JQ et al. (2018) FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-pi interactions. Cell 173, 720&#x2013;734.e15 10.1016/j.cell.2018.03.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.056</ArticleId><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J (2017) Designer protein disaggregases to counter neurodegenerative disease. Curr. Opin. Genet. Dev 44, 1&#x2013;8 10.1016/j.gde.2017.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.01.008</ArticleId><ArticleId IdType="pmc">PMC5447488</ArticleId><ArticleId IdType="pubmed">28208059</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>